The drug-eluting balloon catheter market is a specialized segment of the medical devices industry that is focused on the development and sale of balloon catheters that are coated with a medication designed to prevent restenosis (re-narrowing of the artery) following a procedure such as angioplasty or stenting. These devices are primarily used by interventional cardiologists to treat conditions such as coronary artery disease. The global drug-eluting balloon catheter market is expected to grow in the coming years due to the increasing prevalence of cardiovascular disease worldwide, as well as the growing adoption of minimally invasive procedures for the treatment of cardiovascular disease. Additionally, technological advancements in drug-eluting balloon catheter design and manufacturing are expected to drive market growth.
Some of the major players in the drug-eluting balloon catheter market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, and Koninklijke Philips N.V., among others. These companies offer a range of drug-eluting balloon catheters for the treatment of various types of cardiovascular disease, including both coronary artery disease and peripheral artery disease. In addition to drug-eluting balloon catheters, other types of catheters and stents are also used for the treatment of cardiovascular disease. For example, bare-metal stents are used to prop open blocked arteries, while drug-eluting stents release medication into the artery to prevent restenosis.
Overall, the drug-eluting balloon catheter market is expected to continue to grow as the demand for minimally invasive procedures for the treatment of cardiovascular disease increases and as technology continues to advance in the field of drug-eluting balloon catheter design and manufacturing.
Download Free Sample Copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=146
Key findings of the Drug Eluting Balloon Catheter market study:
MaKey Segments of Drug Eluting Balloon Catheter Industry Surveyrket Taxonomy
· By Indication:
· By End User:
· By Raw Material:
Competitive Landscape
The Drug Eluting Balloon Catheter industry is dominated by some prominent players including
The competition in the sector is driven by key parameters such as product price, targeted customer base, and strategic marketing. Major players in the market focused on the Drug Eluting Balloon Catheter market innovation by investing more in research and development. Furthermore, the industry players are focusing on the extensive usage of online distribution channels for enhanced cost-effectiveness. The sustainability in the supply chain is a decisive factor for Drug Eluting Balloon Catheter brands leading to an impact on the margin profits of firms.
Report Benefits & Key Questions Answered
Interested to Procure The Data? Inquire here at – https://www.factmr.com/checkout/146
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com
Written By
The autologous fat grafting market is anticipated to witness substantial growth, with a robust compound annual growth rate (CAGR) of nearly 10% during the period from 2021 to 2031. Among various applications, breast augmentation emerges as the dominant segment, capturing a significant market share of over 45%. Autologous Fat Grafting, also known as fat transfer or lipofilling, has emerged as a ...
The osseointegration implants market is projected to witness substantial growth, with an estimated valuation of US$ 2.52 billion by the year 2022. Furthermore, this market is anticipated to expand at a robust compound annual growth rate (CAGR) of 8% and reach a sig...
The projected valuation of the trauma care centres market is estimated to reach USD 28.58 billion by the year 2032, reflecting a compound annual growth rate (CAGR) of 7.50% during the period from 2022 to 2032. Furthermore, it is anticipated that the market value of...
The drug discovery technologies market is projected to generate a revenue of US$ 59 billion in 2022, with an estimated growth to reach US$ 81.5 billion by the conclusion of 2026. This anticipated expansion is attributed to the global demand for drug discovery techn...